SlideShare a Scribd company logo
CHEMISTRY OF
PROSTAGLANDINS,
LEUKOTRIENES AND
THROMBOXANES
Presenting by,
Mr Purushotham KN
Asst.Professor
Department of
Pharm.Chemistry.
SACCP,B.G.Nagara
2021-2022
CONTENTS :-
Eicosanoids
1. Prostaglandins
 Introduction
 Classification
 Chemical structure
 Biosynthesis of Prostaglandin
 Regulation of Prostaglandin
 Mechanism of action
 Theraupeutic uses
2. Leukotrienes
 Introduction
 Biosynthesis of Leukotrienes
 Mechanism of action
 Function of Leukotrienes
3. Thromboxanes
 Introduction
 Biosynthesis of Thromboxanes
 Function of Thromboxanes
 Application
Eicosanoids
INTRODUCTION
Eicosanoids are oxidised derivatives of 20-carbon
polyunsaturated fatty acids (PUFAs) formed by the
cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome .
Eicosanoids are Classified as
1. Prostanoids
• Prostaglandins
• Prostacyclins
• Thromboxanes
2. Leukotrienes
• Leukotrienes A4
• Leukotrienes B4
• Leukotrienes C4
• LeukotrienesD4
• Leukotrienes E4
3. Lipoxins
• Lipoxins A4
• Lipoxins B4
All Eicosanoids contain 20 carbon atom
Eicosanoids are considred as Locally acting hormone with wide
range of biochemical Function
And also Arachidonic acid is Precursor of eicosanoids in human
beings.
Prostaglandins
Introduction
CH3
O
OH
1
2
3
4
5
6
7
8
9
10
11 12
13
14
15
16
17
18
19
20
Prostanoic acid
 The prostaglandins (PG) are a group
of physiologically active lipid compounds
called eicosanoids having diverse hormone-like effects in
animals. Prostaglandins have been found in almost every tissue in
humans and other animals. They are derived enzymatically from
the fatty acid that is arachidonic acid
 Prostaglandin are derivative from hypothetical 20 carbon fatty
acid which is called as prostanoic acid and hence the name is
prostanoid.
The prostanoid has a 5 carbon cyclopentane ring which is form by
carbon 8 to carbon 12 and it has 2 side chain 1 chain of 7 carbons
these lied above plane of ring and other chain has below the ring.
Each of the biological active prostaglandin it has a hydroxyl
group at carbon number 15.
Classification of Prostaglandins
 There is 9 classes of Prostaglandins that are
 Prostaglandin A, Prostaglandin B, Prostaglandin C, Prostaglandin
D, Prostaglandin E, Prostaglandin F, Prostaglandin G,
Prostaglandin H, Prostaglandin I
 Prostaglandin are classified into three series.
 1 series which consist 1 double bond from linoleic acid
Prostaglandin E1.
 2 series which consist 2 double bond from Arachidonic acid
Prostaglandin E2.
 3 series which consist 3 double bond from Eicosapentaenoic acid
Prostaglandin E3.
OH
CH3
O
O
H
O OH
Prostaglandin E2
 And double bond between carbon 13 and 14 various
substituent at the cyclopentane ring.
 And also these structure has keto group at carbon 9 and
hydroxyl group at carbon 11.
Chemical structures
OH
CH3
O
H
O OH
O
H
Prostaglandin F2
These is the structure of Prostaglandine F2.
It has hydroxyl group at carbon number 9 and 11.
As other biologically active prostaglandin it has hydroxyl
group at carbon number 15.
double bond between 13 and 14.
Chemical structure of prostacyclins
Prostacyclins contain additional ring formed by cyclization of
side chain by linkage of carbon 6 to carbon 9 through oxygen
atom on that why it is called as Prostacyclins.
O
O
H
O
OH
O
H
CH3
Thromboxane had derivatives of oxane ring and it is a six memebered
ring intrepted by oxygen atom. these is interupted by oxygen ring and
also they are synthesized from arachidonic acid.
And also it synthesize in human body and it has additional oxygen
atom joined with carbon 9 and 11.
Prostaglandin are derivative of prostanoic acid which is 20 carbon
fatty acid and they are most potent biologically substances.
It produced in almost tissue except erythrocytes.
Thromboxane
Prostaglandin are different from true hormone in human body
Prostaglandins are thought to be local hormone secrete by prostate
hormone.
And also prostaglandin were first isolated from prostate gland
secreation hence it named as prostaglandin.
Sweedish scientist Ulf van euler got nobel prize in 1970 for
discovery of prostaglandin.
Prostaglandin actually derived from fatty acid called as Arachidonic
acid which is 20 Carbon fatty acid.
Biosynthesis of Prostaglandin
 At cellular level where are the prostaglandins produced and also
prostaglandin are very unstable compound and there half life
around 30 seconds.
 Prostaglandin synthesis is take place from the membrane
phospholipids.
 From the memebrane phospholipid it is cleaved by phospholipid
A2 It release precurser for prostaglandin synthesis which is
arachidonic acid.
 From that arachidonic acid in sequential enzymatic step
prostaglandin would be produced.
 This crucial step whenever it is required synthesize phospholipid
A2 releases arachidonic acid from membrane phospholipid there
by prostaglandin synthesis takes place.
 Now key enzyme for prostaglandin synthesis pathway is
Prostaglandin H synthase.
 Prostaglandin H synthase has 2 kind of activity one
cyclooxygenase activity and peroxidase activity.
 Cyclooxygenase activity forms prostaglandin G2 from
arachidonic acid.
 And also peroxidase activity that reduces prostaglandin G2 to
prostaglandin H2.
Regulation of Prostaglandin production
 The prostaglandin the key raw material of prostaglandin
production is arachidonic acid derived from cell membrane.
 And it is triggered by a enzyme which is phospholipase A2.
 Now modulating phospholipase A2 activity the prostaglandin
production from arachidonic acid derived from cell membrane.
 And it is triggered by a enzyme which is phospholipase A2
activity the prostaglandin production can be regulated.
 It turns out epinephrine Thrombin, Angiotensin ll , Bradykinin,
vasopressin are positively regulate phospholiphase A2 and that
leads to production of prostaglandin.
 Steroid kind of inhibit prostaglandin A2 activity and there by
prevent production of prostaglandin.
 Prostaglandin H synthase its activity triggered by cathecolamines.
 Where as it inhibit by compound like methyl salysilate and similar
compound like aspirin and others.
Mechanism of Action
 Prostaglandin found to be working G protein couple receptor
signalling pathway.
 An often prostaglandin stimulation leads to increase in cyclic
Amp and protein kinase.
 A activation followed by several nuclear changes in terms of
chin expression.
 Several Prostaglandin has several effect on different level
example prostaglandin I2 leads to vascular dilation.
 Whereas thromboxanes which is secreated or prevently present in
thrombocyte they induce vasoconstriction.
 And also these two has opposite function.
 Now prostaglandin I2 which is known as prostacyclin prevent
platelet aggregation.
 Where as thromboxanes promote platelet aggregation.
 In which prostaglandin F2 are stimulates uterine muscle
contraction sometimes used to terminate pregnancy.
 Now Prostaglandin E and Prostaglandin F has opposing role in
terms of broncho constriction and broncho dilation.
 Prostaglandin F leads bronchial smooth muscle constriction
where PGE leads to dilation of the bronchials.
 Prostaglandin E2 and Prostaglandin D2 increase capillary
permeability enabling neutrophill and other imune cell to be
extravated from particular blood capillary near by the tissue and
it also implicate in terms of inflamation.
So that Prostaglandin E2 and prostaglandin D2 are involved in
inflammatory responses.
Now overall prostaglandin prevent are decrease gastric
secreation and increase intestinal mobility.
THERAUPEUTIC USES
Abortion : PGs have a place in midterm abortion, missed
abortion. Methotrexate alongwith misoprostol is also highly
successful for inducing abortion in the first few weeks of
pregnancy. Pretreatment with mifepristone improves the efficacy
of PGE2 as abortifacient.
Cervical priming : Applied Intravaginally or in the cervical
canal, low doses of PGE2 which do not affect uterine motility,
make the cervix soft and compliant.
Glaucoma : Topical PGF2a analogues like lanatoprost, bimatoprost
that are receptor agonists are the first choice drugs in wide angle
glaucoma.
Peptic ulcer : PGEI (misoprostol) is occasionally used for healing
peptic ulcer.
Avoid Platelet damage : PGI2 (Epoprostenol) can be used to
prevent platelet aggregation and damage during haemodialysis.
Leukotrienes
INTRODUCTION
 Leukotrienes is kind of similar leukocytes. It kind of
associated with Leukocytes.
 Trienes are tell us some features of chemical.
 There are 3 consecutive double bond.
 Now we understand leukotrienes as kind of chemical
molecules which might have chemical features 3
consecutive double bond found in leukocytes.
 So these leukotrienes are actually a family of eicosanoids
(arachidonic acid derivatives).
 Leukotrienes are inflammatory mediators just like other
arachidonic derivative such as prostaglandin.
 Leukotrienes are a family of eicosanoid inflammatory
mediators produced in leukocytes by the oxidation of arachidonic
acid (AA) and the essential fatty acid eicosapentaenoic acid (EPA)
by the enzyme arachidonate 5-lipoxygenase.
 Leukotrienes use lipid signaling to convey information to either the
cell producing them (autocrine signaling) or neighboring cells
(paracrine signaling) in order to regulate immune responses.
 The production of leukotrienes is usually accompanied by the
production of histamine and prostaglandins, which also act as
inflammatory mediators.
5-lip-oxygenase act on arachidonic acid to form 5-
hydroperoxyeicosatetraenoic acid .
Acts and associate with 5-lox activating protein.
The 5HPETE later converted into leukotriene A4 also it is unstable
and rapidly hydrolyse by the action of enzyme by leukotriene A4
hydrolase to form leukotriene B4 in neutrophils and monocytes.
The LTB4 is one of the most potent inflammation mediating lipids.
And LTA4 (Leukotriene A4) which forms leukotriene C4 which
incorporate with glutathion and with action of LTC4 synthase it
forms leukotrienes C4.
Biosynthesis of Leukotrienes
This forms in mast cells and eosinophills.
Later Leukotriene C4 release glutamate to forms leukotriene D4.
Later leukotriene D4 release glycine it forms leukotriene E4.
MECHANISM OF ACTION
 Which is usually accompanied with the production of
prostaglandins and histamines which are inflamattory
mediators from arachidonic acid there could be production of
leukotrienes and also in otherside which form prostaglandin
derivatives which also take part in inflammatory response.
 Leukotrienes receptors are class of G-Protein couple receptor
so generally work by elevation of cyclic Amp in the cell and
leads to several inflammatory cytokinin genes.
 But few leukotrienes receptor also nuclear receptor type.
 And these receptor generally found in easinophil, endothelial
cells, mast cells.
 In endothelial cells and also found in smooth muscles cells
important role in smooth muscle contraction and they form
physiological role incase of disease.
Function of Leukotrienes
Major role of leukotrienes (specially, leukotrienes D4) is to trigger
contraction in the smooth muscle lining the bronchioles.
Contraction of branchioles is triggered by leukotriene and these is
the key underline feature rhinitis or asthma like diseases.
Leukotrienes contribute to the pathophysiology of asthma,
especially in patients with aspirin. Exacerbated respiratory disease
whose symptoms are
Airflow obstruction, Increased secretion of mucus, Mucosal
accumulation, Broncho constriction, Infiltration of inflammatory
cells in the airway wall.
Excess of leukotriene leads to anaphylactic shock.
Excess of leukotriene leads to anaphylactic shock
And also leukotrienes inhibitors could be useful for patients with later
stages of alzheimer disease.
And also improve memory loss
And also Leukotrienes classified as
Leukotrienes A4
Leukotrienes B4
Leukotrienes C4
Leukotrienes D4
Leukotrienes E4
Leukotrienes designated as 4 because 4 double bond in their structures
are
Leukotrienes are involved in the inflammation and immediate
hypersensitivity reaction.
Leukotriene B4
 Increased chemotaxis of polymorphonuclear leukocytes.
 Chemotaxis are directed migration of cell in response to
chemical stimulus such as growth factor.
 Release of lysosomal enzymes, adesion of white blood cells.
Leukotriene C4 , Leukotriene D4, Leukotriene E4
• Involved in contraction of smooth muscle.
• They cause Bronchoconstriction, and Vasoconstriction.
• They also called as slow reacting substance of anaphylaxis.
• Anaphylaxis is seveir potentially life threatening allergic reaction.
• And this reaction occur within seconds or minutes of exposure to
allergens.
Thromboxanes
INTRODUCTION
 Thromboxane is named for its role in clot formation.
 Thromboxane is a member of the family of lipids known as
eicosanoids and also it is derived from arachidonic acid.
 Arachidonic acid get converted into thromboxane A2 and
thromboxane B2.
 Key enzyme help in these process is known as
thromboxane-A-synthase.
 Both thromboxanes are characterized as 6-membered ether
containing cyclic ring.
Biosynthesis of Thromboxanes
o Thromboxanes is synthesized in platelet.
o On the platelet membrane they would be phospholiphase and these
would generate arachidonic acid.
o The arachidonic acid converted initially prostaglandin H2 with the
help of cyclo oxygenase.
o Later prostaglandin H2 is converted into either prostacyclin with the
help of prostacyclin synthase or it can converted into thromboxane
A2 with the help of Thromboxane A synthase.
o These Thromboxane A Synthase enzyme exclusively present in the
platelet membrane. Platelet is the site of thromboxane production.
Thromboxane once generated can bind to thromboxane receptor
present in wide variety of cell for example blood vessel.
Thromboxane ultimately leads to G-protein mediating signalling
which elevates calcium level in cytoplasm.
Once calcium level elevated it helps in clot formation or
eventually in vasoconstriction.
Function of Thromboxanes
 One of the major function of the thromboxane is to perform
vasoconstriction.
 Thromboxane and prostacyclin has opposite role.
 Prostacyclin has vasodilatory role where as thromboxanes has
vasoconstriction role.
 And also vasoconstriction caused by thromboxanes play a role in
prinz metal ’s angina and blocked coronary artery.
 Any kind of cardiac inflammatory disease one of the leading role
could be played by thromboxanes.
 In immune diet if human body has sufficient omega 3 fatty acid
thromboxane A3 has generated instead of thromboxane A2.
 While thromboxane A2 is potent vasoconstrictor and thromboxane
A3 is less potent vasoconstrictor.
 Vasoconstriction mediated effect is less if diet contain omega 3
fatty acid
 In this synthesis of thromboxane by blocking cycloxygenase
specific substance such has aspirin can block production of
thromboxane.
 Other than thromboxane synthase inhibitor inhibit thromboxane
A-synthase.
APPLICATION OF THROMBOXANES
 Thromboxanes exert hormone-like Application.
 They interact with G-protein-linked receptors on the cell surface
to activate signal transduction pathways inside the cell.
 TXs modify inflammatory responses but are most well-known for
their role in platelet aggregation, vasoconstriction, and smooth
muscle proliferation – they are an essential part of the wound
repair mechanism.
 Thromboxane synthesis and thus platelet aggregation is inhibited
by non-steroidal anti-inflammatory drugs like aspirin.
References
 https://pubmed.ncbi.nlm.nih.gov/32808658/#:~:text=Eicosanoids%20
are%20oxidised%20derivatives%20of,usual%20substrate%20for%20
eicosanoid%20synthesis.
 Medical pharmacology by KD Tripathi, 8th edition Page no-197 to
208.
 Medicinal chemistry by Prof. Surendra Nath Pandeya Page no- 239 to
249.
 https://en.m.wikipedia.org/wiki/Thromboxane#:~:text=Thromboxane
%20is%20a%20vasoconstrictor%20and,from%20platelets%20is%20s
till%20unclear.
 https://en.m.wikipedia.org/wiki/Prostaglandin
 https://en.m.wikipedia.org/wiki/Leukotriene
 Medicinal chemistry by K.Ilango & P valentina Page no-968-999.
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

More Related Content

What's hot

H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
Sanjay Gopi
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
JACOB THON BIOR
 
Cholinergic neurotransmitters & Parasympathomimetic agents
Cholinergic neurotransmitters & Parasympathomimetic agentsCholinergic neurotransmitters & Parasympathomimetic agents
Cholinergic neurotransmitters & Parasympathomimetic agents
Subham Kumar Vishwakarma
 
Cardiac Glycosides (Medicinal Chemistry) MANIK
Cardiac Glycosides (Medicinal Chemistry) MANIKCardiac Glycosides (Medicinal Chemistry) MANIK
Cardiac Glycosides (Medicinal Chemistry) MANIK
Imran Nur Manik
 
Drugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-AntipsychoticsDrugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-Antipsychotics
Baddi University of Emerging sciences and Technology
 
MORPHINE AS A LEAD DRUG MOLECULE COMPOUND
MORPHINE AS A LEAD DRUG MOLECULE COMPOUNDMORPHINE AS A LEAD DRUG MOLECULE COMPOUND
MORPHINE AS A LEAD DRUG MOLECULE COMPOUND
Shikha Popali
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
PurushothamKN1
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
abdulla saad zaghloul
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
AkshayYadav176
 
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal ChemistryNon-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Dr. Gopal Krishna Padhy
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
Ajay Kumar
 
STEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptxSTEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptx
AchalYawalkar
 
curare alkaloids.pptx
curare alkaloids.pptxcurare alkaloids.pptx
curare alkaloids.pptx
KomalJAIN122
 
Heterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal DakhaleHeterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal Dakhale
VishalDakhale
 
local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry
NarminHamaaminHussen
 
named reaction.pptx
named reaction.pptxnamed reaction.pptx
named reaction.pptx
DhanashreeKavhale
 
Medicinal Chemistry Complete Notes
Medicinal Chemistry Complete NotesMedicinal Chemistry Complete Notes
Medicinal Chemistry Complete Notes
Ghulam Murtaza Hamad
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
Nirali Mistry
 
Practical Experiment 5: Phenytoin
Practical Experiment 5: Phenytoin Practical Experiment 5: Phenytoin
Practical Experiment 5: Phenytoin
SONALI PAWAR
 

What's hot (20)

H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
 
Cholinergic neurotransmitters & Parasympathomimetic agents
Cholinergic neurotransmitters & Parasympathomimetic agentsCholinergic neurotransmitters & Parasympathomimetic agents
Cholinergic neurotransmitters & Parasympathomimetic agents
 
Cardiac Glycosides (Medicinal Chemistry) MANIK
Cardiac Glycosides (Medicinal Chemistry) MANIKCardiac Glycosides (Medicinal Chemistry) MANIK
Cardiac Glycosides (Medicinal Chemistry) MANIK
 
Drugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-AntipsychoticsDrugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-Antipsychotics
 
MORPHINE AS A LEAD DRUG MOLECULE COMPOUND
MORPHINE AS A LEAD DRUG MOLECULE COMPOUNDMORPHINE AS A LEAD DRUG MOLECULE COMPOUND
MORPHINE AS A LEAD DRUG MOLECULE COMPOUND
 
01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx01.Rational Design of Enzyme inhibition.pptx
01.Rational Design of Enzyme inhibition.pptx
 
Cox 1,2 inhibitors
Cox 1,2 inhibitorsCox 1,2 inhibitors
Cox 1,2 inhibitors
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
 
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal ChemistryNon-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
Non-Steroidal Anti-inflammatory Drugs (NSAID)-Medicinal Chemistry
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
 
STEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptxSTEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptx
 
curare alkaloids.pptx
curare alkaloids.pptxcurare alkaloids.pptx
curare alkaloids.pptx
 
Heterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal DakhaleHeterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal Dakhale
 
local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry local anesthetics / Medicinal Chemistry
local anesthetics / Medicinal Chemistry
 
named reaction.pptx
named reaction.pptxnamed reaction.pptx
named reaction.pptx
 
Medicinal Chemistry Complete Notes
Medicinal Chemistry Complete NotesMedicinal Chemistry Complete Notes
Medicinal Chemistry Complete Notes
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
 
Practical Experiment 5: Phenytoin
Practical Experiment 5: Phenytoin Practical Experiment 5: Phenytoin
Practical Experiment 5: Phenytoin
 

Similar to Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
PharmTecM
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical students
dinesh kumar
 
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINSSYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
chandraprakash dwivedi
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
Dipesh Tamrakar
 
Postaglandines
PostaglandinesPostaglandines
Postaglandines
Joon Jyoti Sahariah
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
Rajendra Dev Bhatt
 
PROSTAGLANDINS
PROSTAGLANDINSPROSTAGLANDINS
PROSTAGLANDINS
YESANNA
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
Darpan Phagiwala
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
Bhagya Siripalli
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
Monika Uma Shankar
 
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdfc. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
VISHALJADHAV100
 
Eocosanoids
EocosanoidsEocosanoids
Eocosanoids
dnyanesh amle
 
eicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phdeicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phd
KawukiIsah
 
PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF
RamaRao Sankula
 
eicosanoids_1.ppt
eicosanoids_1.ppteicosanoids_1.ppt
eicosanoids_1.ppt
zelekeamen7
 
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,LecturerProstaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Dr. Jibachha Sah
 
Prostaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological ImportanceProstaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological Importance
PRUTHVIRAJ K
 

Similar to Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx (20)

Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
 
New style prostaglandins
New style prostaglandins New style prostaglandins
New style prostaglandins
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical students
 
Prostaglandins pharmacology
Prostaglandins pharmacologyProstaglandins pharmacology
Prostaglandins pharmacology
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINSSYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Postaglandines
PostaglandinesPostaglandines
Postaglandines
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
 
PROSTAGLANDINS
PROSTAGLANDINSPROSTAGLANDINS
PROSTAGLANDINS
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdfc. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
 
Eocosanoids
EocosanoidsEocosanoids
Eocosanoids
 
eicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phdeicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phd
 
PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF
 
eicosanoids_1.ppt
eicosanoids_1.ppteicosanoids_1.ppt
eicosanoids_1.ppt
 
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,LecturerProstaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
 
Prostaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological ImportanceProstaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological Importance
 

More from PurushothamKN1

SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
PurushothamKN1
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
PurushothamKN1
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
PurushothamKN1
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
PurushothamKN1
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
PurushothamKN1
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
PurushothamKN1
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
PurushothamKN1
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
PurushothamKN1
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
PurushothamKN1
 
analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
PurushothamKN1
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
PurushothamKN1
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
PurushothamKN1
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
PurushothamKN1
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
PurushothamKN1
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
PurushothamKN1
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
PurushothamKN1
 
Rationale of prodrug design.pptx
Rationale of prodrug design.pptxRationale of prodrug design.pptx
Rationale of prodrug design.pptx
PurushothamKN1
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
PurushothamKN1
 
REACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptxREACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptx
PurushothamKN1
 

More from PurushothamKN1 (20)

SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
 
analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
 
Rationale of prodrug design.pptx
Rationale of prodrug design.pptxRationale of prodrug design.pptx
Rationale of prodrug design.pptx
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
 
REACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptxREACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptx
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

  • 1. CHEMISTRY OF PROSTAGLANDINS, LEUKOTRIENES AND THROMBOXANES Presenting by, Mr Purushotham KN Asst.Professor Department of Pharm.Chemistry. SACCP,B.G.Nagara 2021-2022
  • 2. CONTENTS :- Eicosanoids 1. Prostaglandins  Introduction  Classification  Chemical structure  Biosynthesis of Prostaglandin  Regulation of Prostaglandin  Mechanism of action  Theraupeutic uses 2. Leukotrienes  Introduction  Biosynthesis of Leukotrienes  Mechanism of action  Function of Leukotrienes 3. Thromboxanes  Introduction  Biosynthesis of Thromboxanes  Function of Thromboxanes  Application
  • 3. Eicosanoids INTRODUCTION Eicosanoids are oxidised derivatives of 20-carbon polyunsaturated fatty acids (PUFAs) formed by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome . Eicosanoids are Classified as 1. Prostanoids • Prostaglandins • Prostacyclins • Thromboxanes 2. Leukotrienes • Leukotrienes A4 • Leukotrienes B4 • Leukotrienes C4 • LeukotrienesD4 • Leukotrienes E4
  • 4. 3. Lipoxins • Lipoxins A4 • Lipoxins B4 All Eicosanoids contain 20 carbon atom Eicosanoids are considred as Locally acting hormone with wide range of biochemical Function And also Arachidonic acid is Precursor of eicosanoids in human beings.
  • 6.  The prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids having diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals. They are derived enzymatically from the fatty acid that is arachidonic acid  Prostaglandin are derivative from hypothetical 20 carbon fatty acid which is called as prostanoic acid and hence the name is prostanoid.
  • 7. The prostanoid has a 5 carbon cyclopentane ring which is form by carbon 8 to carbon 12 and it has 2 side chain 1 chain of 7 carbons these lied above plane of ring and other chain has below the ring. Each of the biological active prostaglandin it has a hydroxyl group at carbon number 15.
  • 8. Classification of Prostaglandins  There is 9 classes of Prostaglandins that are  Prostaglandin A, Prostaglandin B, Prostaglandin C, Prostaglandin D, Prostaglandin E, Prostaglandin F, Prostaglandin G, Prostaglandin H, Prostaglandin I  Prostaglandin are classified into three series.  1 series which consist 1 double bond from linoleic acid Prostaglandin E1.  2 series which consist 2 double bond from Arachidonic acid Prostaglandin E2.  3 series which consist 3 double bond from Eicosapentaenoic acid Prostaglandin E3.
  • 9. OH CH3 O O H O OH Prostaglandin E2  And double bond between carbon 13 and 14 various substituent at the cyclopentane ring.  And also these structure has keto group at carbon 9 and hydroxyl group at carbon 11. Chemical structures
  • 10. OH CH3 O H O OH O H Prostaglandin F2 These is the structure of Prostaglandine F2. It has hydroxyl group at carbon number 9 and 11. As other biologically active prostaglandin it has hydroxyl group at carbon number 15. double bond between 13 and 14.
  • 11. Chemical structure of prostacyclins Prostacyclins contain additional ring formed by cyclization of side chain by linkage of carbon 6 to carbon 9 through oxygen atom on that why it is called as Prostacyclins.
  • 13. Thromboxane had derivatives of oxane ring and it is a six memebered ring intrepted by oxygen atom. these is interupted by oxygen ring and also they are synthesized from arachidonic acid. And also it synthesize in human body and it has additional oxygen atom joined with carbon 9 and 11. Prostaglandin are derivative of prostanoic acid which is 20 carbon fatty acid and they are most potent biologically substances. It produced in almost tissue except erythrocytes. Thromboxane
  • 14. Prostaglandin are different from true hormone in human body Prostaglandins are thought to be local hormone secrete by prostate hormone. And also prostaglandin were first isolated from prostate gland secreation hence it named as prostaglandin.
  • 15. Sweedish scientist Ulf van euler got nobel prize in 1970 for discovery of prostaglandin. Prostaglandin actually derived from fatty acid called as Arachidonic acid which is 20 Carbon fatty acid.
  • 16. Biosynthesis of Prostaglandin  At cellular level where are the prostaglandins produced and also prostaglandin are very unstable compound and there half life around 30 seconds.  Prostaglandin synthesis is take place from the membrane phospholipids.  From the memebrane phospholipid it is cleaved by phospholipid A2 It release precurser for prostaglandin synthesis which is arachidonic acid.  From that arachidonic acid in sequential enzymatic step prostaglandin would be produced.
  • 17.  This crucial step whenever it is required synthesize phospholipid A2 releases arachidonic acid from membrane phospholipid there by prostaglandin synthesis takes place.  Now key enzyme for prostaglandin synthesis pathway is Prostaglandin H synthase.  Prostaglandin H synthase has 2 kind of activity one cyclooxygenase activity and peroxidase activity.  Cyclooxygenase activity forms prostaglandin G2 from arachidonic acid.  And also peroxidase activity that reduces prostaglandin G2 to prostaglandin H2.
  • 18.
  • 19.
  • 20. Regulation of Prostaglandin production  The prostaglandin the key raw material of prostaglandin production is arachidonic acid derived from cell membrane.  And it is triggered by a enzyme which is phospholipase A2.  Now modulating phospholipase A2 activity the prostaglandin production from arachidonic acid derived from cell membrane.  And it is triggered by a enzyme which is phospholipase A2 activity the prostaglandin production can be regulated.  It turns out epinephrine Thrombin, Angiotensin ll , Bradykinin, vasopressin are positively regulate phospholiphase A2 and that leads to production of prostaglandin.
  • 21.  Steroid kind of inhibit prostaglandin A2 activity and there by prevent production of prostaglandin.  Prostaglandin H synthase its activity triggered by cathecolamines.  Where as it inhibit by compound like methyl salysilate and similar compound like aspirin and others.
  • 22.
  • 23. Mechanism of Action  Prostaglandin found to be working G protein couple receptor signalling pathway.  An often prostaglandin stimulation leads to increase in cyclic Amp and protein kinase.  A activation followed by several nuclear changes in terms of chin expression.  Several Prostaglandin has several effect on different level example prostaglandin I2 leads to vascular dilation.
  • 24.  Whereas thromboxanes which is secreated or prevently present in thrombocyte they induce vasoconstriction.  And also these two has opposite function.  Now prostaglandin I2 which is known as prostacyclin prevent platelet aggregation.  Where as thromboxanes promote platelet aggregation.  In which prostaglandin F2 are stimulates uterine muscle contraction sometimes used to terminate pregnancy.  Now Prostaglandin E and Prostaglandin F has opposing role in terms of broncho constriction and broncho dilation.
  • 25.  Prostaglandin F leads bronchial smooth muscle constriction where PGE leads to dilation of the bronchials.  Prostaglandin E2 and Prostaglandin D2 increase capillary permeability enabling neutrophill and other imune cell to be extravated from particular blood capillary near by the tissue and it also implicate in terms of inflamation. So that Prostaglandin E2 and prostaglandin D2 are involved in inflammatory responses. Now overall prostaglandin prevent are decrease gastric secreation and increase intestinal mobility.
  • 26. THERAUPEUTIC USES Abortion : PGs have a place in midterm abortion, missed abortion. Methotrexate alongwith misoprostol is also highly successful for inducing abortion in the first few weeks of pregnancy. Pretreatment with mifepristone improves the efficacy of PGE2 as abortifacient. Cervical priming : Applied Intravaginally or in the cervical canal, low doses of PGE2 which do not affect uterine motility, make the cervix soft and compliant.
  • 27. Glaucoma : Topical PGF2a analogues like lanatoprost, bimatoprost that are receptor agonists are the first choice drugs in wide angle glaucoma. Peptic ulcer : PGEI (misoprostol) is occasionally used for healing peptic ulcer. Avoid Platelet damage : PGI2 (Epoprostenol) can be used to prevent platelet aggregation and damage during haemodialysis.
  • 28. Leukotrienes INTRODUCTION  Leukotrienes is kind of similar leukocytes. It kind of associated with Leukocytes.  Trienes are tell us some features of chemical.  There are 3 consecutive double bond.  Now we understand leukotrienes as kind of chemical molecules which might have chemical features 3 consecutive double bond found in leukocytes.  So these leukotrienes are actually a family of eicosanoids (arachidonic acid derivatives).
  • 29.  Leukotrienes are inflammatory mediators just like other arachidonic derivative such as prostaglandin.  Leukotrienes are a family of eicosanoid inflammatory mediators produced in leukocytes by the oxidation of arachidonic acid (AA) and the essential fatty acid eicosapentaenoic acid (EPA) by the enzyme arachidonate 5-lipoxygenase.  Leukotrienes use lipid signaling to convey information to either the cell producing them (autocrine signaling) or neighboring cells (paracrine signaling) in order to regulate immune responses.  The production of leukotrienes is usually accompanied by the production of histamine and prostaglandins, which also act as inflammatory mediators.
  • 30.
  • 31. 5-lip-oxygenase act on arachidonic acid to form 5- hydroperoxyeicosatetraenoic acid . Acts and associate with 5-lox activating protein. The 5HPETE later converted into leukotriene A4 also it is unstable and rapidly hydrolyse by the action of enzyme by leukotriene A4 hydrolase to form leukotriene B4 in neutrophils and monocytes. The LTB4 is one of the most potent inflammation mediating lipids. And LTA4 (Leukotriene A4) which forms leukotriene C4 which incorporate with glutathion and with action of LTC4 synthase it forms leukotrienes C4. Biosynthesis of Leukotrienes
  • 32. This forms in mast cells and eosinophills. Later Leukotriene C4 release glutamate to forms leukotriene D4. Later leukotriene D4 release glycine it forms leukotriene E4.
  • 33.
  • 34.
  • 35. MECHANISM OF ACTION  Which is usually accompanied with the production of prostaglandins and histamines which are inflamattory mediators from arachidonic acid there could be production of leukotrienes and also in otherside which form prostaglandin derivatives which also take part in inflammatory response.  Leukotrienes receptors are class of G-Protein couple receptor so generally work by elevation of cyclic Amp in the cell and leads to several inflammatory cytokinin genes.  But few leukotrienes receptor also nuclear receptor type.
  • 36.  And these receptor generally found in easinophil, endothelial cells, mast cells.  In endothelial cells and also found in smooth muscles cells important role in smooth muscle contraction and they form physiological role incase of disease.
  • 37. Function of Leukotrienes Major role of leukotrienes (specially, leukotrienes D4) is to trigger contraction in the smooth muscle lining the bronchioles. Contraction of branchioles is triggered by leukotriene and these is the key underline feature rhinitis or asthma like diseases. Leukotrienes contribute to the pathophysiology of asthma, especially in patients with aspirin. Exacerbated respiratory disease whose symptoms are Airflow obstruction, Increased secretion of mucus, Mucosal accumulation, Broncho constriction, Infiltration of inflammatory cells in the airway wall.
  • 38. Excess of leukotriene leads to anaphylactic shock.
  • 39. Excess of leukotriene leads to anaphylactic shock And also leukotrienes inhibitors could be useful for patients with later stages of alzheimer disease. And also improve memory loss And also Leukotrienes classified as Leukotrienes A4 Leukotrienes B4 Leukotrienes C4 Leukotrienes D4 Leukotrienes E4 Leukotrienes designated as 4 because 4 double bond in their structures are
  • 40. Leukotrienes are involved in the inflammation and immediate hypersensitivity reaction. Leukotriene B4  Increased chemotaxis of polymorphonuclear leukocytes.  Chemotaxis are directed migration of cell in response to chemical stimulus such as growth factor.  Release of lysosomal enzymes, adesion of white blood cells.
  • 41. Leukotriene C4 , Leukotriene D4, Leukotriene E4 • Involved in contraction of smooth muscle. • They cause Bronchoconstriction, and Vasoconstriction. • They also called as slow reacting substance of anaphylaxis. • Anaphylaxis is seveir potentially life threatening allergic reaction. • And this reaction occur within seconds or minutes of exposure to allergens.
  • 42. Thromboxanes INTRODUCTION  Thromboxane is named for its role in clot formation.  Thromboxane is a member of the family of lipids known as eicosanoids and also it is derived from arachidonic acid.  Arachidonic acid get converted into thromboxane A2 and thromboxane B2.  Key enzyme help in these process is known as thromboxane-A-synthase.  Both thromboxanes are characterized as 6-membered ether containing cyclic ring.
  • 43.
  • 44. Biosynthesis of Thromboxanes o Thromboxanes is synthesized in platelet. o On the platelet membrane they would be phospholiphase and these would generate arachidonic acid. o The arachidonic acid converted initially prostaglandin H2 with the help of cyclo oxygenase. o Later prostaglandin H2 is converted into either prostacyclin with the help of prostacyclin synthase or it can converted into thromboxane A2 with the help of Thromboxane A synthase. o These Thromboxane A Synthase enzyme exclusively present in the platelet membrane. Platelet is the site of thromboxane production.
  • 45. Thromboxane once generated can bind to thromboxane receptor present in wide variety of cell for example blood vessel. Thromboxane ultimately leads to G-protein mediating signalling which elevates calcium level in cytoplasm. Once calcium level elevated it helps in clot formation or eventually in vasoconstriction.
  • 46.
  • 47. Function of Thromboxanes  One of the major function of the thromboxane is to perform vasoconstriction.  Thromboxane and prostacyclin has opposite role.  Prostacyclin has vasodilatory role where as thromboxanes has vasoconstriction role.  And also vasoconstriction caused by thromboxanes play a role in prinz metal ’s angina and blocked coronary artery.  Any kind of cardiac inflammatory disease one of the leading role could be played by thromboxanes.  In immune diet if human body has sufficient omega 3 fatty acid thromboxane A3 has generated instead of thromboxane A2.
  • 48.  While thromboxane A2 is potent vasoconstrictor and thromboxane A3 is less potent vasoconstrictor.  Vasoconstriction mediated effect is less if diet contain omega 3 fatty acid  In this synthesis of thromboxane by blocking cycloxygenase specific substance such has aspirin can block production of thromboxane.  Other than thromboxane synthase inhibitor inhibit thromboxane A-synthase.
  • 49. APPLICATION OF THROMBOXANES  Thromboxanes exert hormone-like Application.  They interact with G-protein-linked receptors on the cell surface to activate signal transduction pathways inside the cell.  TXs modify inflammatory responses but are most well-known for their role in platelet aggregation, vasoconstriction, and smooth muscle proliferation – they are an essential part of the wound repair mechanism.  Thromboxane synthesis and thus platelet aggregation is inhibited by non-steroidal anti-inflammatory drugs like aspirin.
  • 50.
  • 51. References  https://pubmed.ncbi.nlm.nih.gov/32808658/#:~:text=Eicosanoids%20 are%20oxidised%20derivatives%20of,usual%20substrate%20for%20 eicosanoid%20synthesis.  Medical pharmacology by KD Tripathi, 8th edition Page no-197 to 208.  Medicinal chemistry by Prof. Surendra Nath Pandeya Page no- 239 to 249.  https://en.m.wikipedia.org/wiki/Thromboxane#:~:text=Thromboxane %20is%20a%20vasoconstrictor%20and,from%20platelets%20is%20s till%20unclear.  https://en.m.wikipedia.org/wiki/Prostaglandin  https://en.m.wikipedia.org/wiki/Leukotriene  Medicinal chemistry by K.Ilango & P valentina Page no-968-999.